131 related articles for article (PubMed ID: 7780546)
1. [Treatment of growth hormone deficiencies with growth hormone releasing hormone. Current status and perspectives].
Auzerie J; Colle M; Guinot P; Lavergne V
Arch Pediatr; 1995 Apr; 2(4):365-72. PubMed ID: 7780546
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone-releasing hormone: therapeutic perspectives.
Gelato MC; Malozowski S; Pescovitz OH; Cassorla F; Loriaux DL; Merriam GR
Pediatrician; 1987; 14(3):162-7. PubMed ID: 3134651
[TBL] [Abstract][Full Text] [Related]
3. [Growth hormone-releasing factor (GRF) in the treatment of the child with a growth hormone (GH) deficiency].
Lanes R
An Esp Pediatr; 1992 Jun; 36 Suppl 48():169-71. PubMed ID: 1636959
[No Abstract] [Full Text] [Related]
4. Short-term effect on growth of two doses of GRF 1-44 in children with growth hormone deficiency: comparison with growth induced by methionyl-GH administration.
Wit JM; Otten BJ; Waelkens JJ; Oostdijk W; Krabbe J; Rochefort JG; Van den Brande JL
Horm Res; 1987; 27(4):181-9. PubMed ID: 3125098
[TBL] [Abstract][Full Text] [Related]
5. Human growth hormone-releasing hormone (hGH-RH; hGRF) treatment of four patients with GH deficiency.
Takano K; Hizuka N; Asakawa K; Chihara K; Sanayama K; Shizume K
Endocrinol Jpn; 1988 Oct; 35(5):775-81. PubMed ID: 3146502
[TBL] [Abstract][Full Text] [Related]
6. [Somatocrinin induces growth hormone release in a case of growth hormone deficiency of hypothalamic origin in a child].
Sassolas G; Rousset H; Cohen R; Chatelain P; Claustrat B; Laporte S; Laferrère B; El Charfi A; Ferry S
C R Seances Acad Sci III; 1983; 296(11):527-30. PubMed ID: 6409361
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous treatment with growth hormone-releasing hormone for short stature.
Hernández M; Fragoso J; Barrio R; Argente J; Arilla E
Horm Res; 1988; 30(6):252-7. PubMed ID: 2907992
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal pulsatile growth hormone releasing hormone treatment in growth hormone deficiency.
Smith PJ; Brook CG; Rivier J; Vale W; Thorner MO
Clin Endocrinol (Oxf); 1986 Jul; 25(1):35-44. PubMed ID: 3098459
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone releasing factor may lower somatotropin demand.
Ziporyn T
JAMA; 1984 Sep; 252(10):1257-9. PubMed ID: 6433048
[No Abstract] [Full Text] [Related]
10. Growth hormone therapy of short stature.
Knudtzon J
Acta Paediatr Scand; 1986 May; 75(3):353-61. PubMed ID: 3088905
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of growth hormone deficiencies by GHRH].
Rochiccioli P; Tauber M
Ann Pediatr (Paris); 1989 May; 36(5):293-7. PubMed ID: 2500885
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone.
Kiess W; Malozowski S; Gelato M; Butenand O; Doerr H; Crisp B; Eisl E; Maluish A; Belohradsky BH
Clin Immunol Immunopathol; 1988 Jul; 48(1):85-94. PubMed ID: 3133146
[TBL] [Abstract][Full Text] [Related]
13. [Growth hormone-releasing hormone (GHRH) as a diagnostic and therapeutic agent].
Oostdijk W
Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():24-6. PubMed ID: 3137695
[No Abstract] [Full Text] [Related]
14. Growth hormone-releasing hormone and growth hormone-releasing peptide as potential therapeutic modalities.
Thorner MO; Vance ML; Rogol AD; Blizzard RM; Veldhuis JD; Cauter EV; Copinschi G; Bowers CY
Acta Paediatr Scand Suppl; 1990; 367():29-32. PubMed ID: 1977276
[No Abstract] [Full Text] [Related]
15. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
[TBL] [Abstract][Full Text] [Related]
16. Long term pulsatile growth hormone (GH)-releasing hormone therapy in children with GH deficiency.
Low LC; Wang C; Cheung PT; Ho P; Lam KS; Young RT; Yeung CY; Ling N
J Clin Endocrinol Metab; 1988 Mar; 66(3):611-7. PubMed ID: 3127420
[TBL] [Abstract][Full Text] [Related]
17. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
Lifshitz F; Lanes R; Pugliese M; Fort P; Perez I; Puentes S; Cervantes C; Gunczler P; Chasalow FI; Recker B
J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
[TBL] [Abstract][Full Text] [Related]
18. Acceleration of growth rate in growth hormone-deficient children treated with human growth hormone-releasing hormone.
Thorner MO; Rogol AD; Blizzard RM; Klingensmith GJ; Najjar J; Misra R; Burr I; Chao G; Martha P; Mcdonald J
Pediatr Res; 1988 Aug; 24(2):145-51. PubMed ID: 3141891
[TBL] [Abstract][Full Text] [Related]
19. [Current status of somatocrinin, or GRF, a hypothalamic growth hormone-secreting factor].
Sassolas G; Guillemin R
Ann Endocrinol (Paris); 1986; 47(5):332-41. PubMed ID: 3103519
[TBL] [Abstract][Full Text] [Related]
20. Effect of repeated subcutaneous administration of growth hormone releasing factor (GRF 1-44) on hypophysis in GH-deficient children.
Szarras-Czapnik M; Rymkiewicz-Kluczyńska B; Romer T
Endokrynol Pol; 1987; 38(1):15-9. PubMed ID: 3123207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
